Mabwell (Shanghai) Bioscience Sets 1 June 2026 EGM to Approve Up to RMB1.00 Billion Targeted Debt Financing

Bulletin Express05-06

Mabwell (Shanghai) Bioscience Co., Ltd. (MABWELL-B) has called its 2026 second extraordinary general meeting (EGM) for 3:00 p.m. on Monday, 1 June 2026 at Conference Room 103, Building 3, Chuangxiang Park, No. 576 Libing Road, Pudong New Area, Shanghai.

The sole ordinary resolution seeks shareholder approval for the Company’s application to register and issue targeted debt-financing instruments with a maximum aggregate size of RMB1.00 billion.

Key timetable • Register of members (H shares) closed: 27 May 2026–1 June 2026 (both days inclusive) • Record date for voting entitlement: 1 June 2026 • Deadline for H-share transfer lodgement: 4:30 p.m., 26 May 2026 • Proxy submission deadline: 3:00 p.m., 31 May 2026

Voting will be conducted by poll in accordance with Hong Kong Listing Rules, and results will be disclosed via the Hong Kong Stock Exchange and the Company’s website.

The meeting will be conducted in Mandarin and is expected to last no longer than half a day. Shareholders attending in person or by proxy will bear their own expenses, and no gifts or securities will be distributed.

As of the notice date (7 May 2026), the Board comprises five executive directors (Mr. Tang Chunshan; Dr. Liu Datao—Chairman; Dr. Wu Hai; Mr. Hu Huiguo; Dr. Gui Xun), one non-executive director (Mr. Wu Yufeng) and four independent non-executive directors (Mr. Qin Zhengyu; Dr. Xu Qing; Dr. Zhao Qian; Ms. Wang Fang).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1127675446?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 23:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127675446","market":"us","top_or_hot":-1,"title":"Mabwell (Shanghai) Bioscience Sets 1 June 2026 EGM to Approve Up to RMB1.00 Billion Targeted Debt Financing","media":"Bulletin Express","content":"<p>Mabwell (Shanghai) Bioscience Co., Ltd. (MABWELL-B) has called its 2026 second extraordinary general meeting (EGM) for 3:00 p.m. on Monday, 1 June 2026 at Conference Room 103, Building 3, Chuangxiang Park, No. 576 Libing Road, Pudong New Area, Shanghai.</p>\n<p>The sole ordinary resolution seeks shareholder approval for the Company’s application to register and issue targeted debt-financing instruments with a maximum aggregate size of RMB1.00 billion.</p>\n<p>Key timetable  \n•   Register of members (H shares) closed: 27 May 2026–1 June 2026 (both days inclusive)  \n•   Record date for voting entitlement: 1 June 2026  \n•   Deadline for H-share transfer lodgement: 4:30 p.m., 26 May 2026  \n•   Proxy submission deadline: 3:00 p.m., 31 May 2026</p>\n<p>Voting will be conducted by poll in accordance with Hong Kong Listing Rules, and results will be disclosed via the Hong Kong Stock Exchange and the Company’s website.</p>\n<p>The meeting will be conducted in Mandarin and is expected to last no longer than half a day. Shareholders attending in person or by proxy will bear their own expenses, and no gifts or securities will be distributed.</p>\n<p>As of the notice date (7 May 2026), the Board comprises five executive directors (Mr. Tang Chunshan; Dr. Liu Datao—Chairman; Dr. Wu Hai; Mr. Hu Huiguo; Dr. Gui Xun), one non-executive director (Mr. Wu Yufeng) and four independent non-executive directors (Mr. Qin Zhengyu; Dr. Xu Qing; Dr. Zhao Qian; Ms. Wang Fang).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mabwell (Shanghai) Bioscience Sets 1 June 2026 EGM to Approve Up to RMB1.00 Billion Targeted Debt Financing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMabwell (Shanghai) Bioscience Sets 1 June 2026 EGM to Approve Up to RMB1.00 Billion Targeted Debt Financing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-06 23:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Mabwell (Shanghai) Bioscience Co., Ltd. (MABWELL-B) has called its 2026 second extraordinary general meeting (EGM) for 3:00 p.m. on Monday, 1 June 2026 at Conference Room 103, Building 3, Chuangxiang Park, No. 576 Libing Road, Pudong New Area, Shanghai.</p>\n<p>The sole ordinary resolution seeks shareholder approval for the Company’s application to register and issue targeted debt-financing instruments with a maximum aggregate size of RMB1.00 billion.</p>\n<p>Key timetable  \n•   Register of members (H shares) closed: 27 May 2026–1 June 2026 (both days inclusive)  \n•   Record date for voting entitlement: 1 June 2026  \n•   Deadline for H-share transfer lodgement: 4:30 p.m., 26 May 2026  \n•   Proxy submission deadline: 3:00 p.m., 31 May 2026</p>\n<p>Voting will be conducted by poll in accordance with Hong Kong Listing Rules, and results will be disclosed via the Hong Kong Stock Exchange and the Company’s website.</p>\n<p>The meeting will be conducted in Mandarin and is expected to last no longer than half a day. Shareholders attending in person or by proxy will bear their own expenses, and no gifts or securities will be distributed.</p>\n<p>As of the notice date (7 May 2026), the Board comprises five executive directors (Mr. Tang Chunshan; Dr. Liu Datao—Chairman; Dr. Wu Hai; Mr. Hu Huiguo; Dr. Gui Xun), one non-executive director (Mr. Wu Yufeng) and four independent non-executive directors (Mr. Qin Zhengyu; Dr. Xu Qing; Dr. Zhao Qian; Ms. Wang Fang).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02493","symbol_name":"迈威生物-B","start_time":0,"source_url":"","article_id":"1127675446","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127675446","pubTimestamp":1778079764,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (MABWELL-B) has called its 2026 second extraordinary general meeting (EGM) for 3:00 p.m. on Monday, 1 June 2026 at Conference Room 103, Building 3, Chuangxiang...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02493":"迈威生物-B"},"translate_title":"迈博威（上海）生物科技定于2026年6月1日举行的临时股东大会批准最多人民币10亿元的定向债务融资","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02493":1},"content_text":"Mabwell (Shanghai) Bioscience Co., Ltd. (MABWELL-B) has called its 2026 second extraordinary general meeting (EGM) for 3:00 p.m. on Monday, 1 June 2026 at Conference Room 103, Building 3, Chuangxiang Park, No. 576 Libing Road, Pudong New Area, Shanghai.\nThe sole ordinary resolution seeks shareholder approval for the Company’s application to register and issue targeted debt-financing instruments with a maximum aggregate size of RMB1.00 billion.\nKey timetable  \n•   Register of members (H shares) closed: 27 May 2026–1 June 2026 (both days inclusive)  \n•   Record date for voting entitlement: 1 June 2026  \n•   Deadline for H-share transfer lodgement: 4:30 p.m., 26 May 2026  \n•   Proxy submission deadline: 3:00 p.m., 31 May 2026\nVoting will be conducted by poll in accordance with Hong Kong Listing Rules, and results will be disclosed via the Hong Kong Stock Exchange and the Company’s website.\nThe meeting will be conducted in Mandarin and is expected to last no longer than half a day. Shareholders attending in person or by proxy will bear their own expenses, and no gifts or securities will be distributed.\nAs of the notice date (7 May 2026), the Board comprises five executive directors (Mr. Tang Chunshan; Dr. Liu Datao—Chairman; Dr. Wu Hai; Mr. Hu Huiguo; Dr. Gui Xun), one non-executive director (Mr. Wu Yufeng) and four independent non-executive directors (Mr. Qin Zhengyu; Dr. Xu Qing; Dr. Zhao Qian; Ms. Wang Fang).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1127675446","isCrawlerRequest":true}